Similarly, Shen et al. [29] also showed significantly higher TWIST1 expression in patients with type I endometrial cancer compared to normal endometrium, and aberrant TWIST1 expression was significantly associated with clinical parameters, indicating poor prognosis and shorter patient survival. This evidence concerns the gene TWIST1 and endometrial cancer.